The flows also show how the “regulated stack” is broadening. Until recently, traders looking to short, lever up, or run basis strategies in anything beyond BTC and ETH were pushed offshore to Binance or OKX. CME’s push into Solana and XRP pulls some of that business into its clearinghouse, where collateral rules and accounting treatment are friendlier to funds.
The more liquidity migrates to CME, the easier it becomes for traditional desks to justify crypto allocations.
It’s no accident that the conversation around Solana futures ETFs is running in parallel: derivatives depth is a prerequisite for ETF approval.
Some of that is cyclical. Crypto is bigger now, with ETFs and institutional rails already in place. But part of it is specific: funds are clearly seeking exposure to Solana and XRP as distinct trades, not just as “altcoin beta.”
Solana’s throughput and huge DeFi/consumer stack make it a clear bet on “Ethereum-style” activity at a faster clip. For XRP, it’s the regulatory clarity after Ripple’s courtroom wins and the token’s legacy role in cross-border settlement. Both assets now have credible narratives that can be expressed in size through CME.
What this really signals is that the CME crypto mix is shifting from a duopoly to a portfolio. BTC and ETH still dominate, but the rise of XRP and Solana futures means that Q4 could be the first time traditional desks are genuinely running multi-asset crypto books inside a US-regulated clearinghouse.
If options follow, that portfolio expands into structured products, risk-transfer trades, and eventually ETF fuel.
